Диссертация (Клинические и иммуноморфологические особенности преэклампсии в обосновании предиктивной, превентивной, персонифицированной системы ведения беременных), страница 56
Описание файла
Файл "Диссертация" внутри архива находится в папке "Клинические и иммуноморфологические особенности преэклампсии в обосновании предиктивной, превентивной, персонифицированной системы ведения беременных". PDF-файл из архива "Клинические и иммуноморфологические особенности преэклампсии в обосновании предиктивной, превентивной, персонифицированной системы ведения беременных", который расположен в категории "". Всё это находится в предмете "медицина" из Аспирантура и докторантура, которые можно найти в файловом архиве МГМУ им. Сеченова. Не смотря на прямую связь этого архива с МГМУ им. Сеченова, его также можно найти и в других разделах. , а ещё этот архив представляет собой докторскую диссертацию, поэтому ещё представлен в разделе всех диссертаций на соискание учёной степени доктора медицинских наук.
Просмотр PDF-файла онлайн
Текст 56 страницы из PDF
BMC Immunol. 2010 Dec 2;11:59.323. Takase B, Hamabe A, Satomura K, Akima T, Uehata A, Ohsuzu F, IshiharaM, Kurita A. Close relationship between the vasodilator response to acetylcholinein the brachial and coronary artery in suspected coronary artery disease. Int JCardiol. 2005 Oct 20;105(1):58-66.324. Takeuchi M, Matsuzaki K, Harada M, Nishitani H, Matsuda T. Cerebralhyperperfusion in a patient with eclampsia with perfusion-weighted magneticresonance imaging. Radiat Med. 2005 Aug;23(5):376-9.325. Tan, C.Y., Ho, J.F., Chong, Y.S., Loganath, A., Chan, Y.H., Ravichandran,J., Lee, C.G., Chong, S.S.
Paternal contribution of HLA-G*0106 significantlyincreases risk for preeclampsia in multigravid pregnancies. Mol. Hum. Reprod.2008;14:317–324.326. Tastekin A., Ors R., Demircan B., Saricam Z., Ingec M., Akcay F.Oxidative stress in infants born to preeclamptic mothers. Pediatr Int 2005Dec;47(6):658-62.327. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease.Immunol Rev (2008) 223:87–113.328.
Thangaratinam S, Langenveld J, Mol BW, Khan KS. Prediction and primaryprevention of pre-eclampsia. Best Pract Res Clin Obstet Gynaecol. 2011Aug;25(4):419-33.329. Tranquilli AL. Early and late-onset pre-eclampsia. Pregnancy Hypertens.2014 Jul;4(3):241.330. Urato A.C., Norwitz E.R. A guide towards pre-pregnancy management ofdefective implantation and placentation Best Practice & Research ClinicalObstetrics and Gynaecology. 2011; 25: 367–387.331.
Uzan J., Carbonnel M., Piconne O., Asmar R., Ayoub J.-M. Pre-eclampsia:pathophysiology, diagnosis, and management. Vascular Health and RiskManagement. 2011;7:467–474.345332. van den Elzen HJ, Cohen-Overbeek TE, Grobbee DE, Quartero RWP,Wladimiroff JW. Early uterine artery Doppler velocimetry and the outcome ofpregnancy in women aged 35years and older. Ultrasound Obstet Gynecol.1995;5:328–333.333. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM,Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'AmorePA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, KarumanchiSA. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med2006; 12: 642–649.334.
Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG,Pape J, Dudenhausen JW, Denk B, Stepan H. An automated method for thedetermination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am JObstet Gynecol. 2010 Feb;202(2):161.e1-161.e11.335. Villa P, Kajantie E, Räikkönen K, Pesonen AK et al. Aspirin in theprevention of pre-eclampsia in high-risk women: a randomised placebo-controlledPREDO Trial and a meta-analysis of randomised trials.
BJOG. 2013Jan;120(1):64-74.336. Vintzileos AM, Ananth CV. First trimester prediction of ischemic placentaldisease. Semin Perinatol. 2014 Apr;38(3):159-166.337. Voltolini C, Petraglia F. Neuroendocrinology of pregnancy and parturition.Handb Clin Neurol. 2014;124:17-36.338. Von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA.Fall in mean arterial pressure and fetal growth restriction in pregnancyhypertension: a meta-analysis. Lancet.
2000; 355(9198): 87–92.339. Wang A, Rana S, Karumanchi SA. Preeclampsia: the role of angiogenicfactors in its pathogenesis. Physiology (Bethesda). 2009 Jun;24:147-58.340. Wang J.X., Knottnerus A.M., Schuit G., Norman R.J., Chan A., DekkerG.A. Surgically obtained sperm, and risk of gestational hypertension andpreeclampsia. Lancet 2002;359:673–674.346341. Warrington JP, Fan F, Murphy SR, Roman RJ, Drummond HA, Granger JP,Ryan MJ. Placental ischemia in pregnant rats impairs cerebral blood flowautoregulation and increases blood-brain barrier permeability.
Physiol Rep. 2014Aug 28; 2(8): e12134.342. Wasseff S. Mechanisms of convulsions in eclampsia. Med Hypotheses. 2009Jan;72(1):49-51.343. Wathén KA, Tuutti E, Stenman UH, Alfthan H, Halmesmäki E, Finne P,Ylikorkala O, Vuorela P. Maternal serum-soluble vascular endothelial growthfactor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growthretardation. J Clin Endocrinol Metab. 2006 Jan;91(1):180-4.344. Weiss G, Goldsmith LT, Taylor RN, Bellet D, Taylor HS.
Inflammation inreproductive disorders. Reprod Sci (2009) 16(2):216–29.345. Wide-Swensson D, Strevens H, Willner J. Antepartum percutaneous renalbiopsy. Int J Gynaecol Obstet 2007;98:88–92.346. Wolin MS, Gupte SA, Neo BH, Gao Q, Ahmad M. Oxidant-redox regulationof pulmonary vascular responses to hypoxia and nitric oxide-cGMP signaling.Cardiol Rev 2010;18:89–93.347. World Health Organization. WHO Recommendations for prevention andtreatmentofpre-eclampsiaandeclampsia.Geneva,2011(http://www.ncbi.nlm.nih.gov/books/NBK140561/?report= reader#!po= 16.6667).348. Wortelboer EJ, Koster MP, Cuckle HS, Stoutenbeek PH, Schielen PC,Visser GH. First-trimester placental protein 13 and placental growth factor:markers for identification of women destined to develop early-onset pre-eclampsia.BJOG.
2010 Oct;117(11):1384-1389.349. Wright D, Akolekar R, Syngelaki A, Poon LCY, Nicolaides KH. Acompeting risks model in early screening for preeclampsia. Fetal Diagn Ther.2012;32:171–178.350. Xia Y, Ramin SM, Kellems RE. Potential Roles of Angiotensin ReceptorActivating Autoantibody in the Pathophysiology of Preeclampsia. Hypertension.2007;50:269–275.347351. Yaron Y, Cherry M, Kramer RL, O'Brien JE, Hallak M, Johnson MP, EvansMI. Second-trimester maternal serum marker screening: maternal serum alphafetoprotein, beta-human chorionic gonadotropin, estriol,and their variouscombinations as predictors of pregnancy outcome.
Am JObstetGynecol.1999;181:968–974.352. Yinon Y, Kingdom JC, Odutayo A, Moineddin R, Drewlo S, Lai V, CherneyDZ, Hladunewich MA. Vascular dysfunction in women with a history ofpreeclampsia and intrauterine growth restriction: insights into future vascular risk.Circulation.2010;122(18):1846–1853.353. Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia.Annu Rev Pathol. 2010;5:173-92.354. Yulug E, Yenilmez E, Unsal MA, Aydin S, Tekelioglu Y, Arvas H.Apoptotic and morphological features of the umbilical artery endothelium in mildand severe pre-eclampsia.
Acta Obstet Gynecol Scand 2006;85(9):1038-45.355. Yung HW, Atkinson D, Campion-Smith T, Olovsson M, Charnock-JonesDS, Burton GJ. Differential activation of placental unfolded protein responsepathways implies heterogeneity in causation of early- and late-onset pre-eclampsia.J Pathol. 2014 Oct;234(2):262-76.356.Zeeman GG, Cipolla MJ, Cunningham G. The brain in hypertensivedisorders of pregnancy. In: Hypertensive Disorders in Pregnancy, Lindheimer,Roberts and Cunningham. Elsevier: San Diego, 2009, Chapter 13 227–247.357. Zeeman GG, Fleckenstein JL, Twickler DM, Cunningham FG.
Cerebralinfarction in eclampsia. Am J Obstet Gynecol. 2004 Mar;190(3):714-20.358. Zeeman GG, Hatab M, Twickler DM. Maternal cerebral blood flow changesin pregnancy. Am J Obstet Gynecol 2003; 189: 968–972.359. Zeeman GG. Neurologic complications of pre-eclampsia. Semin Perinatol.2009 Jun;33(3):166-72.360. Zhang Y, Zhong M, Liu F. Low molecular weight heparin inhibits cellapoptosis in the placenta of rats withpreeclampsia-like symptoms.
Nan Fang Yi KeDa Xue Xue Bao. 2012 Jun; 32(6): 862-6.348361. Zhao Y, Zheng YF, Luo QQ, Yan T, Liu XX, Han L, Zou L. Edaravoneinhibitshypoxia-inducedtrophoblast-solubleFms-liketyrosinekinase1expression: a possible therapeutic approach to preeclampsia. Placenta. 2014Jul;35(7):476-82.362.
Zhu X.M., Han T., Sargent I.L., Yin G.W., Yao Y.Q. Differential expressionprofile of microRNAs in human placentas from preeclamptic pregnancies vsnormal pregnancies. Am. J. Obstet. Gynecol. 2009;200:661.e1–661.e7.363. Zimmermann B, El-Sheikhah A, Nicolaides K, Holzgreve W, Hahn S.Optimized real-time quantitative PCR measurement of male fetal DNA in maternalplasma. Clin Chem. 2005;51:1598–1604.364. Zunker P, Happe S. Georgiadis AL, Louwen F, Georgiadis D, RingelsteinEB, Holgreve W. Maternal cerebral hemodynamics in pregnancy-relatedhypertension. A prospective transcranial Doppler study. Ultrasound ObstetGynecol. 2000;16:179 –18.349.
